T1	Drug_or_compound 0 11	Aflibercept
T2	Drug_or_compound 13 20	AVE0005
T4	Pathological_formation 62 68	tumour
T6	Gene_or_gene_product 85 120	vascular endothelial growth factors
T10	Gene_or_gene_product 306 310	VEGF
T16	Gene_or_gene_product 501 505	VEGF
T18	Gene_or_gene_product 539 543	VEGF
T21	Gene_or_gene_product 587 594	VEGFR-1
T22	Gene_or_gene_product 598 605	VEGFR-2
T24	Gene_or_gene_product 627 631	VEGF
T25	Drug_or_compound 636 662	tyrosine kinase inhibitors
T26	Gene_or_gene_product 666 672	VEGFRs
T27	Drug_or_compound 794 805	aflibercept
T28	Gene_or_gene_product 851 858	VEGFR-1
T29	Gene_or_gene_product 875 882	VEGFR-2
T31	Drug_or_compound 922 933	Aflibercept
T32	Drug_or_compound 1044 1055	aflibercept
T3	Gene_or_gene_product 907 911	IgG1
T1000	Organism 453 461	patients
T1001	Organism 1066 1074	patients
T30	Protein_domain_or_region 892 903	Fc fragment
T17	Gene_or_gene_product 525 543	antibodies to VEGF
T19	Gene_or_gene_product 598 605	VEGFR-2
T20	Gene_or_gene_product 545 594	antibodies to the extracellular domain of VEGFR-1
T33	Pathological_formation 182 188	cancer
T36	Pathological_formation 446 452	cancer
T37	Pathological_formation 1059 1065	cancer
